India’s Wockhardt to recall some drugs made in India after U.S. FDA concerns

Indian generic drugmaker Wockhardt Ltd said on Tuesday it would recall some drugs manufactured at its two plants in India before the U.S. Food and Drug Administration (FDA) banned those sites due to quality concerns.

The FDA banned U.S. exports from Wockhardt’s Waluj and Chikalthana plants in central India in 2013, citing manufacturing quality lapses.

see

http://www.pharmalive.com/indias-wockhardt-to-recall-some-drugs-made-in-india-after-u-s-fda-concerns/